Internal Medicine, Gastroenterology · San Antonio, TX
NPI
1295814952
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8550 Datapoint Dr, Suite 200
San Antonio, TX, 78229
Phone (210) 615-8308
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
3,046 services
Medicare patients, 2024
499
Average age 74
Drug cost, 2024
$1.5M
1,493 prescriptions
Company payments, 2025
$126K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles W Randall was code 99439 (chronic, principal, and transitional care management), 406 times for 51 patients. In total Charles W Randall billed 3,046 services in 46 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 406 | 51 | $36.28 | $15K |
| 88305 Surgical Pathology Examination | Office | 371 | 152 | $25.40 | $9,425 |
| 99213 Office E&M - Established | Office | 275 | 197 | $55.78 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 224 | 51 | $47.34 | $11K |
| 99214 Office E&M - Established | Office | 197 | 140 | $89.58 | $18K |
| 99443 Telephone Services | Office | 181 | 120 | $63.99 | $12K |
| 91065 Test - Miscellaneous | Office | 96 | 29 | $53.47 | $5,133 |
| 45380 Lower GI Endoscopy - Other | Facility | 82 | 81 | $72.07 | $5,910 |
| 45385 Colonoscopy - Lesion Removal | Facility | 68 | 68 | $156.07 | $11K |
| 99203 Office E&M - New | Office | 64 | 64 | $71.78 | $4,594 |
| 43239 Upper GI Endoscopy | Facility | 61 | 59 | $67.56 | $4,121 |
| 88342 Immunohistochemistry | Office | 49 | 45 | $53.34 | $2,614 |
| 76981 Ultrasound - Nonspecific | Office | 43 | 43 | $72.98 | $3,138 |
| 88313 Surgical Pathology Examination | Office | 43 | 32 | $51.42 | $2,211 |
| 99212 Office E&M - Established | Office | 42 | 42 | $40.83 | $1,715 |
By year: 2022 $207K for 4,663 services; 2023 $136K for 2,778 services; 2024 $141K for 3,046 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 371 | 152 | $25.40 | $9,425 |
| 88342 Immunohistochemistry | 49 | 45 | $53.34 | $2,614 |
| 88313 Surgical Pathology Examination | 43 | 32 | $51.42 | $2,211 |
| 88341 Immunohistochemistry | 34 | 20 | $46.92 | $1,595 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles W Randall prescribed most often to Medicare patients was Pantoprazole Sodium, with 231 prescriptions and refills. In total Charles W Randall wrote 1,493 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 231 | 580 | 66 | $2,238 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 220 | 220 | 212 | $14K |
| Desipramine Hcl Generic | 88 | 130 | 25 | $3,730 |
| Linzess Linaclotide | 75 | 126 | 22 | $63K |
| Dicyclomine Hcl Generic | 73 | 120 | 25 | $1,799 |
| Zenpep Lipase/Protease/Amylase | 61 | 79 | 15 | $97K |
| Omeprazole Generic | 61 | 173 | 22 | $1,102 |
| Creon Lipase/Protease/Amylase | 42 | 55 | 13 | $107K |
| Amitriptyline Hcl Generic | 39 | 68 | Under 11 | $446 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 37 | 37 | 36 | $6,753 |
| Dexlansoprazole Dr Dexlansoprazole | 33 | 81 | 11 | $10K |
| Mounjaro Tirzepatide | 31 | 31 | Under 11 | $33K |
| Lansoprazole Generic | 27 | 77 | Under 11 | $1,272 |
| Alosetron Hcl Generic | 22 | 22 | Under 11 | $7,950 |
| Stelara Ustekinumab | 20 | 39 | Under 11 | $725K |
Brand drugs: 521 claims; generic drugs: 972 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles W Randall $126K ($126K in general payments such as food, travel and fees) from 26 companies. The largest payer was Janssen Biotech, Inc. with $81K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 96 | $81K |
| Lilly USA, LLC LLY | 31 | $26K |
| Abbvie Inc. ABBV | 34 | $16K |
| Aimmune Therapeutics, Inc. | 14 | $268 |
| Genzyme Corporation SNY | 6 | $244 |
| Celltrion USA Inc. 068270.KS | 14 | $235 |
| Ardelyx, Inc. ARDX | 5 | $224 |
| Pfizer Inc. PFE | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 9 | $145 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.